The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Vaccines for preventing pneumococcal infection in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2013
|
| DOI | 10.1002/14651858.cd000422.pub3 |
| Pubmed ID | |
| Authors |
Sarah Moberley, John Holden, David Paul Tatham, Ross M Andrews |
| Abstract |
Diseases caused by Streptococcus pneumoniae (S. pneumoniae) continue to cause substantial morbidity and mortality globally. Whilst pneumococcal polysaccharide vaccines (PPVs) have the potential to prevent disease and death, the degree of protection afforded against various clinical endpoints and within different populations is uncertain. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 8% |
| Mexico | 1 | 4% |
| United Kingdom | 1 | 4% |
| Finland | 1 | 4% |
| Australia | 1 | 4% |
| Unknown | 19 | 76% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 92% |
| Scientists | 1 | 4% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 490 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 4 | <1% |
| United Kingdom | 4 | <1% |
| Germany | 2 | <1% |
| Kenya | 1 | <1% |
| Canada | 1 | <1% |
| Switzerland | 1 | <1% |
| Denmark | 1 | <1% |
| Taiwan | 1 | <1% |
| Spain | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 473 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 73 | 15% |
| Student > Master | 58 | 12% |
| Student > Bachelor | 57 | 12% |
| Student > Ph. D. Student | 40 | 8% |
| Other | 37 | 8% |
| Other | 105 | 21% |
| Unknown | 120 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 193 | 39% |
| Nursing and Health Professions | 28 | 6% |
| Agricultural and Biological Sciences | 27 | 6% |
| Immunology and Microbiology | 19 | 4% |
| Biochemistry, Genetics and Molecular Biology | 16 | 3% |
| Other | 79 | 16% |
| Unknown | 128 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2024.
All research outputs
#813,022
of 26,549,961 outputs
Outputs from Cochrane database of systematic reviews
#1,424
of 13,243 outputs
Outputs of similar age
#6,149
of 296,210 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 167 outputs
Altmetric has tracked 26,549,961 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,243 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,210 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.